Deutsch English Français

Contact

EP1406700

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1406700

EP1406700 - COMPOSITION FOR TOPICAL ADMINISTRATION COMPRISING AN INTERLEUKIN-2 INHIBITOR AND AN ANTIMICROBIAL AGENT [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 29.05.2015 Database last updated on 15.08.2024
Most recent event Tooltip	29.05.2015	Application deemed to be withdrawn	published on 01.07.2015 [2015/27]
Applicant(s)	For all designated states Sucampo AG Graben 5 6300 Zug / CH
	[2004/16]
Inventor(s)	01 / UENO, Ryuji 11025 Stanmore Drive, Potomac Montgomery, MD 20854 / US
	[2004/16]
Representative(s)	Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte Brucknerstraße 20 40593 Düsseldorf / DE
	[N/P]
Former [2004/16]	Gille Hrabal Struck Neidlein Prop Roos Patentanwälte Brucknerstrasse 20 40593 Düsseldorf / DE
Application number, filing date	02741390.5	02.07.2002
	[2004/16]
	WO2002JP06670
Priority number, date	US20010303148P	06.07.2001 Original published format: US 303148 P
	[2004/16]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO03004098
	Date:	16.01.2003
	Language:	EN
	[2003/03]
	Type:	A1 Application with search report
	No.:	EP1406700
	Date:	14.04.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 16.01.2003 takes the place of the publication of the European patent application.
	[2004/16]
Search report(s)	International search report - published on:	EP	16.01.2003
Classification	IPC:	A61P37/06, A61P17/00, A61K31/435, A61K31/495, A61K31/535, A61K38/13	[2004/16]
	CPC:	A61K45/06 (EP,US); A61K38/13 (EP,KR,US); A61K31/436 (EP,US); A61K31/496 (EP,US); A61K31/535 (EP,US); A61P11/00 (EP); (+) A61P11/02 (EP); A61P11/06 (EP); A61P17/00 (EP); A61P17/08 (EP); A61P27/02 (EP); A61P27/12 (EP); A61P27/14 (EP); A61P29/00 (EP); A61P31/00 (EP); A61P31/04 (EP); A61P31/10 (EP); A61P37/06 (EP); A61P37/08 (EP); A61P41/00 (EP); A61P43/00 (EP) (-)
	C-Set:	A61K31/436, A61K2300/00 (EP,US); A61K31/535, A61K2300/00 (US,EP); A61K38/13, A61K2300/00 (US,EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/16]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	ZURBEREITUNG ZUR TOPISCHEN ANWENDUNG ENTHALTEND EINEN INTERLEUKIN-2 INHIBITOR UND EINE ANTIMIKROBIELLE SUBSTANZ	[2004/16]
	English:	COMPOSITION FOR TOPICAL ADMINISTRATION COMPRISING AN INTERLEUKIN-2 INHIBITOR AND AN ANTIMICROBIAL AGENT	[2004/16]
	French:	COMPOSITION POUR ADMINISTRATION DIRECTE COMPRENANT UN INHIBITEUR DE L'INTERLEUKINE 2 ET UN AGENT ANTIMICROBIEN	[2004/16]
Entry into regional phase	10.01.2004	National basic fee paid
	10.01.2004	Designation fee(s) paid
	10.01.2004	Examination fee paid
Examination procedure	22.01.2003	Request for preliminary examination filed International Preliminary Examining Authority: EP
	10.01.2004	Examination requested [2004/18]
	08.07.2009	Despatch of a communication from the examining division (Time limit: M04)
	10.10.2009	Reply to a communication from the examining division
	13.12.2012	Despatch of a communication from the examining division (Time limit: M04)
	04.04.2013	Reply to a communication from the examining division
	02.02.2015	Application deemed to be withdrawn, date of legal effect [2015/27]
	25.02.2015	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2015/27]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 08.07.2009
Fees paid	Renewal fee
	20.07.2004	Renewal fee patent year 03
	26.07.2005	Renewal fee patent year 04
	19.07.2006	Renewal fee patent year 05
	25.07.2007	Renewal fee patent year 06
	22.07.2008	Renewal fee patent year 07
	22.07.2009	Renewal fee patent year 08
	21.07.2010	Renewal fee patent year 09
	19.07.2011	Renewal fee patent year 10
	24.07.2012	Renewal fee patent year 11
	24.07.2013	Renewal fee patent year 12
	Penalty fee
	Additional fee for renewal fee
	31.07.2014	13 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]WO0050007 (LIPOCINE INC [US]) [X] 1-7 * claims 44,45,114,115 *;
		[X]US6248776 (HARRIS JAMES W [US]) [X] 1,2,5-7 * column 36, line 49 - column 38, line 9 *;
		[X]US6312715 (CANTOR ADAM S [US], et al) [X] 1,2,5-7 * column 7, line 27 - column 8, line 32 *;
		[X] - GILLUM J G ET AL, "PHARMACOKINETIC DRUG INTERACTIONS WITH ANTIMICROBIAL AGENTS", CLINICAL PHARMACOKINETICS, LEA & FEBIGER, PHILADELPHIA, PA, US, (1993), vol. 25, no. 6, pages 450 - 482, XP001028138 [X] 1,2,5-7 * page 456, column R, paragraph L - page 457, column L, paragraph 2 * * table III *
		[X] - MCLELLAN ROMAN A ET AL, "Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation.", CLINICAL PHARMACOLOGY & THERAPEUTICS, (1995), vol. 58, no. 3, ISSN 0009-9236, pages 322 - 327, XP001118735 [X] 1,2,5-7 * abstract * * page 326, column L, paragraph 4 - page 326, column R, paragraph L * DOI: http://dx.doi.org/10.1016/0009-9236(95)90249-X
		[X] - PATERSON DAVID L ET AL, "Interactions between tacrolimus and antimicrobial agents.", CLINICAL INFECTIOUS DISEASES, (199712), vol. 25, no. 6, ISSN 1058-4838, pages 1430 - 1440, XP001118720 [X] 1-7 * page 1430, column L, paragraph 4 - page 1430, column R, paragraph 2 * * abstract * * page 1435, column L, paragraph 1 - page 1435, column L, paragraph L * * page 1438, column R, paragraph 2 - page 1438, column R, paragraph L *
		[X] - IWASAKI KAZUHIDE ET AL, "Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes.", RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, (1993), vol. 82, no. 2, ISSN 0034-5164, pages 209 - 216, XP001118085 [X] 1-7 * page 209, paragraph 1 * * page 215, paragraph 2 - page 215, paragraph L *
	by applicant	US4117118
		US4215199
		US4288431
		US4388307
		WO9409010
		US5385907
		US5514686
		WO0066122
		- HELVCHIM.ACTA., (1977), vol. 60, page 1568
		- HEL.CHIM.ACTA., (1982), vol. 65, page 1655
		- TRANSPLANT.PROC., (1985), vol. 17, page 1362
		WO2002JP03664

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p